Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Validation of clinical scores for risk assessment.

van Griensven J, Florence E, Van den Ende J.

Clin Infect Dis. 2012 May;54(10):1520-1; author reply 1521-2. doi: 10.1093/cid/cis263. Epub 2012 Mar 28. No abstract available.

PMID:
22460970
2.

Pneumonia in the community caused by multidrug-resistant organisms: keep working on probabilistic scores.

Aliberti S, Zanaboni AM, Blasi F.

Clin Infect Dis. 2012 May;54(10):1519-20; author reply 1521-2. doi: 10.1093/cid/cis260. Epub 2012 Mar 28. No abstract available.

PMID:
22460972
3.

The challenge of identifying resistant-organism pneumonia in the emergency department: still navigating on the erie canal?

Murri R, De Pascale G.

Clin Infect Dis. 2012 Jan 15;54(2):199-201. doi: 10.1093/cid/cir794. Epub 2011 Nov 21. No abstract available.

PMID:
22109953
4.

Clinical scoring for risk of resistant organisms in pneumonia: right idea, wrong interpretation.

Bowman N, Goswami N, Lippincott CK, Vinikoor MJ, Miller WC.

Clin Infect Dis. 2012 Sep;55(5):749-50. doi: 10.1093/cid/cis532. Epub 2012 Jun 5. No abstract available.

5.

HCAP not busy being born is busy dying.

Ewig S.

Am J Respir Crit Care Med. 2014 Feb 1;189(3):365-6. doi: 10.1164/rccm.201307-1383LE. No abstract available.

PMID:
24484341
6.

Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department.

Shorr AF, Zilberberg MD, Reichley R, Kan J, Hoban A, Hoffman J, Micek ST, Kollef MH.

Clin Infect Dis. 2012 Jan 15;54(2):193-8. doi: 10.1093/cid/cir813. Epub 2011 Nov 21.

PMID:
22109951
7.

Role for risk-scoring tools in identifying resistant pathogens in pneumonia: reassessing the value of healthcare-associated pneumonia as a concept.

Shorr AF, Zilberberg MD.

Curr Opin Pulm Med. 2015 May;21(3):232-8. doi: 10.1097/MCP.0000000000000159. Review.

PMID:
25764018
8.

Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia.

Shorr AF, Zilberberg MD, Micek ST, Kollef MH.

Arch Intern Med. 2008 Nov 10;168(20):2205-10. doi: 10.1001/archinte.168.20.2205.

PMID:
19001196
9.

Editorial Commentary: The Mismatch Between Physicians' Expectations and Microbiologic Reality.

Mortensen EM.

Clin Infect Dis. 2015 Nov 1;61(9):1411-2. doi: 10.1093/cid/civ632. Epub 2015 Jul 29. No abstract available.

PMID:
26223996
10.

[Study of the cases with multidrug-resistant Pseudomonas aeruginosa by sputum culture].

Okimoto N, Nanba F, Kibayashi T, Kishimoto M, Yamato K, Kurihara T, Honda Y, Osaki K, Asaoka N.

Nihon Kokyuki Gakkai Zasshi. 2007 Oct;45(10):755-8. Japanese.

PMID:
18018622
11.

Nosocomial bacterial pneumonia in HIV-infected patients: risk factors for adverse outcome and implications for rational empiric antibiotic therapy.

Franzetti F, Grassini A, Piazza M, Degl'innocenti M, Bandera A, Gazzola L, Marchetti G, Gori A.

Infection. 2006 Feb;34(1):9-16.

PMID:
16501896
12.

[Microbial spectrum of nosocomial pneumonia in traumatological patients].

Avazashvili N, Nozadze T, Chikviladze D, Gachechiladze Kh, Metreveli D, Mikeladze M.

Georgian Med News. 2011 May;(194):76-9. Russian.

PMID:
21685529
13.

Reduction of fluoroquinolone use is associated with a decrease in methicillin-resistant Staphylococcus aureus and fluoroquinolone-resistant Pseudomonas aeruginosa isolation rates: a 10 year study.

Lafaurie M, Porcher R, Donay JL, Touratier S, Molina JM.

J Antimicrob Chemother. 2012 Apr;67(4):1010-5. doi: 10.1093/jac/dkr555. Epub 2012 Jan 11.

PMID:
22240401
14.
15.

Epidemiology of healthcare-associated pneumonia (HCAP).

Zilberberg MD, Shorr AF.

Semin Respir Crit Care Med. 2009 Feb;30(1):10-5. doi: 10.1055/s-0028-1119804. Epub 2009 Feb 6. Review.

PMID:
19199182
16.

Investigation of oral opportunistic pathogens in independent living elderly Japanese.

Ogawa T, Ikebe K, Enoki K, Murai S, Maeda Y.

Gerodontology. 2012 Jun;29(2):e229-33. doi: 10.1111/j.1741-2358.2010.00449.x. Epub 2010 Nov 17.

PMID:
21083745
17.

Bacteremia in Staphylococcus aureus pneumonia: outcomes and epidemiology.

Schreiber MP, Chan CM, Shorr AF.

J Crit Care. 2011 Aug;26(4):395-401. doi: 10.1016/j.jcrc.2010.09.002. Epub 2010 Oct 30.

PMID:
21036521
18.

Registration trials of antibacterial drugs for the treatment of nosocomial pneumonia.

Sorbello A, Komo S, Valappil T, Nambiar S.

Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S36-41. doi: 10.1086/653038. Review.

PMID:
20597669
19.

Use of high-dose 4-hour infusion of doripenem, in combination with fosfomycin, for treatment of carbapenem-resistant Pseudomonas aeruginosa pneumonia.

Apisarnthanarak A, Mundy LM.

Clin Infect Dis. 2010 Dec 1;51(11):1352-4. doi: 10.1086/657249. No abstract available.

PMID:
21050114

Supplemental Content

Support Center